Literature DB >> 35137643

Acceptance of Saliva-Based Specimen Collection for SARS-CoV-2 Testing Among K-12 Students, Teachers, and Staff.

Heather P McLaughlin1, Mary Claire Worrell1, Sara Malone2, Patrick Dawson1,3, Brett Maricque2, Jessica L Halpin1, Sooji Lee1, Stephanie A Fritz2, Sarah C Tinker1, Julie A Neidich2, Katie Towns4, Justin S Lee1, Lisa C Barrios1, John C Neatherlin1, Jason G Newland2, Johanna S Salzer1.   

Abstract

OBJECTIVE: Saliva specimens collected in school populations may offer a more feasible, noninvasive alternative to nasal swabs for large-scale COVID-19 testing efforts in kindergarten through 12th grade (K-12) schools. We investigated acceptance of saliva-based COVID-19 testing among quarantined K-12 students and their parents, teachers, and staff members who recently experienced a SARS-CoV-2 exposure in school.
METHODS: We surveyed 719 participants, in person or by telephone, who agreed to or declined a free saliva-based COVID-19 reverse-transcription polymerase chain reaction test as part of a surveillance investigation about whether they would have consented to testing if offered a nasal swab instead. We conducted this investigation in 6 school districts in Greene County (n = 3) and St. Louis County (n = 3), Missouri, from January 25 through March 23, 2021.
RESULTS: More than one-third (160 of 446) of K-12 students (or their parents or guardians), teachers, and staff members who agreed to a saliva-based COVID-19 test indicated they would have declined testing if specimen collection were by nasal swab. When stratified by school level, 51% (67 of 132) of elementary school students or their parents or guardians would not have agreed to testing if a nasal swab was offered.
CONCLUSIONS: Some students, especially those in elementary school, preferred saliva-based COVID-19 testing to nasal swab testing. Use of saliva-based testing might increase voluntary participation in screening efforts in K-12 schools to help prevent the spread of SARS-CoV-2.

Entities:  

Keywords:  COVID-19; K-12 schools; saliva-based testing; school health; screening

Mesh:

Year:  2022        PMID: 35137643      PMCID: PMC9109545          DOI: 10.1177/00333549221074395

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   3.117


  9 in total

1.  Saliva as an Alternative Specimen for Molecular COVID-19 Testing in Community Settings and Population-Based Screening.

Authors:  Abiola Senok; Hanan Alsuwaidi; Yusrah Atrah; Ola Al Ayedi; Janan Al Zahid; Aaron Han; Asma Al Marzooqi; Saba Al Heialy; Basel Altrabulsi; Laila AbdelWareth; Youssef Idaghdour; Raghib Ali; Tom Loney; Alawi Alsheikh-Ali
Journal:  Infect Drug Resist       Date:  2020-10-01       Impact factor: 4.003

2.  Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis.

Authors:  Guillaume Butler-Laporte; Alexander Lawandi; Ian Schiller; Mandy Yao; Nandini Dendukuri; Emily G McDonald; Todd C Lee
Journal:  JAMA Intern Med       Date:  2021-03-01       Impact factor: 21.873

3.  The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review.

Authors:  Daniel P Oran; Eric J Topol
Journal:  Ann Intern Med       Date:  2021-01-22       Impact factor: 25.391

4.  Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021.

Authors:  Rebecca B Hershow; Karen Wu; Nathaniel M Lewis; Alison T Milne; Dustin Currie; Amanda R Smith; Spencer Lloyd; Brian Orleans; Erin L Young; Brandi Freeman; Noah Schwartz; Bobbi Bryant; Catherine Espinosa; Yoshinori Nakazawa; Elizabeth Garza; Olivia Almendares; Winston E Abara; Daniel C Ehlman; Keith Waters; Mary Hill; Ilene Risk; Kelly Oakeson; Jacqueline E Tate; Hannah L Kirking; Angela Dunn; Snigdha Vallabhaneni; Adam L Hersh; Victoria T Chu
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-03-26       Impact factor: 17.586

5.  Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection.

Authors:  Alvin Kuo Jing Teo; Yukti Choudhury; Iain Beehuat Tan; Chae Yin Cher; Shi Hao Chew; Zi Yi Wan; Lionel Tim Ee Cheng; Lynette Lin Ean Oon; Min Han Tan; Kian Sing Chan; Li Yang Hsu
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

6.  Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020.

Authors:  Patrick Dawson; Mary Claire Worrell; Sara Malone; Sarah C Tinker; Stephanie Fritz; Brett Maricque; Sadaf Junaidi; Gemille Purnell; Albert M Lai; Julie A Neidich; Justin S Lee; Rachel C Orscheln; Rachel Charney; Terri Rebmann; Jon Mooney; Nancy Yoon; Machelle Petit; Spring Schmidt; Jean Grabeel; Lee Ann Neill; Lisa C Barrios; Snigdha Vallabhaneni; Randall W Williams; Clay Goddard; Jason G Newland; John C Neatherlin; Johanna S Salzer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-03-26       Impact factor: 17.586

7.  SARS-CoV-2 Testing Service Preferences of Adults in the United States: Discrete Choice Experiment.

Authors:  Rebecca Zimba; Sarah Kulkarni; Amanda Berry; William You; Chloe Mirzayi; Drew Westmoreland; Angela Parcesepe; Levi Waldron; Madhura Rane; Shivani Kochhar; McKaylee Robertson; Andrew Maroko; Christian Grov; Denis Nash
Journal:  JMIR Public Health Surveill       Date:  2020-12-31

8.  Factors Associated with Participation in Elementary School-Based SARS-CoV-2 Testing - Salt Lake County, Utah, December 2020-January 2021.

Authors:  Nathaniel M Lewis; Rebecca B Hershow; Victoria T Chu; Karen Wu; Alison T Milne; Nathan LaCross; Mary Hill; Ilene Risk; Adam L Hersh; Hannah L Kirking; Jacqueline E Tate; Snigdha Vallabhaneni; Angela C Dunn
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-04-16       Impact factor: 17.586

9.  Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.

Authors:  A David Paltiel; Amy Zheng; Rochelle P Walensky
Journal:  JAMA Netw Open       Date:  2020-07-01
  9 in total
  1 in total

1.  Nasopharyngeal swabs vs. saliva sampling for SARS-CoV-2 detection: A cross-sectional survey of acceptability for caregivers and children after experiencing both methods.

Authors:  François Gagnon; Maala Bhatt; Roger Zemek; Richard J Webster; Stephanie Johnson-Obaseki; Stuart Harman
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.